Blackstone Reportedly Buys Piramal Glass for $1 Billion
Piramal Enterprises is looking to sell some non-core businesses to boost capital. In June, the group agreed to sell a 20 percent stake in Piramal Pharma to Carlyle for $490 million.
Piramal Enterprises is looking to sell some non-core businesses to boost capital. In June, the group agreed to sell a 20 percent stake in Piramal Pharma to Carlyle for $490 million.
